Sex differences in long‐term cardiovascular outcomes among patients with acute myocardial infarction: A population‐based retrospective cohort study

Abstract

Background: Whether a sex difference exists in long-term cardiovascular (CV) outcomes after acute myocardial infarction (AMI) is worth exploration. This study is sought to investigate the relationships among sex, age, and the long-term prognosis after AMI. Methods: This population-based retrospective cohort study used Taiwan's NationalHealth Insurance Research Database to investigate the sex differences in in-hospital and long-term CV outcomes in patients with AMI. We enrolled patients who were first diagnosed with AMI from January 1, 2000 to December 31, 2013. The outcomes of interest included all-cause mortality, CV death, non-fatal stroke, non-fatal heart failure, and AMI recurrence during hospitalization and 5-year follow up. The CV outcomes were also analyzed by age stratification.Results: Overall, 201 921 patients with AMI were analyzed; 68.72% were men and 31.28% were women, with mean ages of 65.34 ± 14.12 and 73.05 ± 12.22 years, respectively. Major adverse cardiac events during hospitalization and up to 5 years were consistently greater in women than in men. Multivariable regression analysis revealed no sex difference existed in long-term all-cause and CV mortality. Men of all age groups consistently showed higher risk of both short-and long-term recurrence of AMI. Nonetheless, the female sex still independently predicted increased risk of non-fatal stroke and heart failure from hospitalization until 3-year follow up. Conclusion:Women with AMI had poorer short-term and long-term outcomes. The sex differences in long-term all-cause and CV death disappear after multivariate analysis. Nonetheless, female AMI patients independently predicted higher risk of stroke and heart failure from hospitalization until a 3-year follow-up. To better understand the pathophysiology of female patients with AMI and develop more effective management, more studies in this field are necessary in the future. | INTRODUC TI ONAcute myocardial infarction (AMI) is one of the most dangerous cardiovascular (CV) diseases, and its long-term prognosis is usually poor.In recent years, with the development of research on and treatment of atherosclerotic CV disease, the death rate of myocardial infarction (MI) at the acute phase has decreased significantly. 1 Because women have traditionally been thought to have less CV disease compared with men, whether a sex difference exists in the prognosis of patients with MI in the acute and long-term stages has always How to cite this article: Chang S-S, Lin S-Y, Lai J-N, et al. Sex differences in long-term cardiovascular outcomes among patients with acute myocardial infarction: A populationbased retrospective cohort study. Int J Clin Pract.

Fear of COVID-19 in Patients with Acute Myocardial Infarction

“…However, this fact is representative of the clinical AMI reality, where there is a male:female event ratio of 5:1 [ 36 ]. However, despite the lower incidence of acute coronary artery disease in females, women have worse short- and long-term outcomes than men [ 37 , 38 ]. Moreover, the pre-hospital delay from symptom onset to admission is generally significantly longer for women also ordinarily [ 39 ].…”

The diagnostic role of resting myocardial blood flow in STEMI patients after revascularization

“…Generally, male individuals have a greater risk of cardiovascular disease than female individuals ( 34 , 35 ). Our study had the same characteristics as the general population distribution; male prevalence was greater, and female patients comprised only 9.33% of the study population.…”

Effects of statins and steroids on coronary artery disease and stroke in patients with interstitial lung disease and pulmonary fibrosis: A general population study

“…However, a ≥20% 10-year ASCVD risk for a composite 3-point major atherosclerotic CV event of nonfatal myocardial infarction, nonfatal stroke, or CV death can serve as an arbitrary definition of patients with very high risk [ 21 ]. Thus, following the practice of the Taiwanese Secondary Prevention for Patients with Atherosclerotic Disease Registry [ 22 , 23 ], we replaced ASCVD with the following ICD-9-CM codes: AMI, 410; other acute and subacute forms of ischemic heart disease, 411; old myocardial infarction, 412; angina pectoris, 413; other forms of chronic ischemic disease, 414; hemorrhagic stroke, 430–432; ischemic stroke, 433–437; peripheral artery disease, 440.0, 440.2, 440.3, 440.8, 440.9, 443, 444.0, 444.22, 444.8, 447.8, and 447.9; arterial revascularization, 36.0–36.3; and operations on heart vessels, 36.9 [ 23 , 24 ]. The major atherosclerotic CV event was replaced with ICD-9-CM codes for all-cause mortality as follows: CV death, 390–459; nonfatal stroke, 430–438; nonfatal heart failure, 428; and AMI, 410.…”